

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.55337419 |
| 2 | DNA deamination (GO:0045006) | 5.53509171 |
| 3 | cytidine catabolic process (GO:0006216) | 5.45666993 |
| 4 | cytidine deamination (GO:0009972) | 5.45666993 |
| 5 | cytidine metabolic process (GO:0046087) | 5.45666993 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.41963703 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.41963703 |
| 8 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.18978718 |
| 9 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.82611168 |
| 10 | negative regulation of mast cell activation (GO:0033004) | 4.78806878 |
| 11 | interferon-gamma production (GO:0032609) | 4.54400114 |
| 12 | protein neddylation (GO:0045116) | 4.05030620 |
| 13 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.91560709 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.83356761 |
| 15 | termination of RNA polymerase III transcription (GO:0006386) | 3.78599495 |
| 16 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.78599495 |
| 17 | respiratory electron transport chain (GO:0022904) | 3.75659187 |
| 18 | GTP biosynthetic process (GO:0006183) | 3.71557058 |
| 19 | behavioral response to nicotine (GO:0035095) | 3.70417264 |
| 20 | electron transport chain (GO:0022900) | 3.69932106 |
| 21 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.66665995 |
| 22 | chaperone-mediated protein transport (GO:0072321) | 3.58813328 |
| 23 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.57225584 |
| 24 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.47555611 |
| 25 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.38624523 |
| 26 | protein K11-linked deubiquitination (GO:0035871) | 3.37880600 |
| 27 | cellular response to interleukin-15 (GO:0071350) | 3.34479821 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 3.32928708 |
| 29 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.32230941 |
| 30 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.28032638 |
| 31 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.28032638 |
| 32 | regulation of chronic inflammatory response (GO:0002676) | 3.24474985 |
| 33 | actin nucleation (GO:0045010) | 3.18337012 |
| 34 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.18237865 |
| 35 | hydrogen ion transmembrane transport (GO:1902600) | 3.16273702 |
| 36 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.15452291 |
| 37 | iron-sulfur cluster assembly (GO:0016226) | 3.07436594 |
| 38 | metallo-sulfur cluster assembly (GO:0031163) | 3.07436594 |
| 39 | piRNA metabolic process (GO:0034587) | 3.07057072 |
| 40 | proton transport (GO:0015992) | 3.03873343 |
| 41 | ATP biosynthetic process (GO:0006754) | 3.01400225 |
| 42 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.00991742 |
| 43 | UTP biosynthetic process (GO:0006228) | 2.98794997 |
| 44 | hydrogen transport (GO:0006818) | 2.96882730 |
| 45 | GPI anchor metabolic process (GO:0006505) | 2.94565634 |
| 46 | T cell costimulation (GO:0031295) | 2.94502248 |
| 47 | eosinophil chemotaxis (GO:0048245) | 2.94053554 |
| 48 | platelet dense granule organization (GO:0060155) | 2.93818530 |
| 49 | sequestering of actin monomers (GO:0042989) | 2.92316347 |
| 50 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.91455498 |
| 51 | lymphocyte costimulation (GO:0031294) | 2.91371015 |
| 52 | protein localization to cilium (GO:0061512) | 2.91107435 |
| 53 | GPI anchor biosynthetic process (GO:0006506) | 2.87495539 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.84850217 |
| 55 | positive regulation of prostaglandin secretion (GO:0032308) | 2.84039941 |
| 56 | positive regulation of mast cell degranulation (GO:0043306) | 2.82486814 |
| 57 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82486814 |
| 58 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.81234908 |
| 59 | protein-cofactor linkage (GO:0018065) | 2.80928990 |
| 60 | protein complex biogenesis (GO:0070271) | 2.79743644 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.78730783 |
| 62 | base-excision repair, AP site formation (GO:0006285) | 2.78566169 |
| 63 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.75256210 |
| 64 | UTP metabolic process (GO:0046051) | 2.74722598 |
| 65 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.73721624 |
| 66 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.72815204 |
| 67 | response to interleukin-15 (GO:0070672) | 2.71388821 |
| 68 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.67927572 |
| 69 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.66713811 |
| 70 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.66713811 |
| 71 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.66713811 |
| 72 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.64709063 |
| 73 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.64709063 |
| 74 | eosinophil migration (GO:0072677) | 2.64519744 |
| 75 | activated T cell proliferation (GO:0050798) | 2.64194408 |
| 76 | negative regulation of T cell apoptotic process (GO:0070233) | 2.63364256 |
| 77 | negative regulation by host of viral transcription (GO:0043922) | 2.63300785 |
| 78 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.62377440 |
| 79 | regulation of action potential (GO:0098900) | 2.62063142 |
| 80 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 2.61967217 |
| 81 | serotonin receptor signaling pathway (GO:0007210) | 2.61932526 |
| 82 | CTP metabolic process (GO:0046036) | 2.61738360 |
| 83 | CTP biosynthetic process (GO:0006241) | 2.61738360 |
| 84 | respiratory chain complex IV assembly (GO:0008535) | 2.61351905 |
| 85 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.60601596 |
| 86 | positive regulation of fatty acid transport (GO:2000193) | 2.57602598 |
| 87 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.55589022 |
| 88 | NADH dehydrogenase complex assembly (GO:0010257) | 2.55589022 |
| 89 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.55589022 |
| 90 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.55101322 |
| 91 | negative regulation of B cell apoptotic process (GO:0002903) | 2.53819676 |
| 92 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 2.53151989 |
| 93 | regulation of T cell chemotaxis (GO:0010819) | 2.52798575 |
| 94 | positive regulation of T cell chemotaxis (GO:0010820) | 2.52798575 |
| 95 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.49061540 |
| 96 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.49061540 |
| 97 | positive regulation of mast cell activation (GO:0033005) | 2.47799886 |
| 98 | arginine metabolic process (GO:0006525) | 2.47758383 |
| 99 | signal peptide processing (GO:0006465) | 2.46717291 |
| 100 | peroxisome fission (GO:0016559) | 2.46520542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.14916591 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.07000294 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.02530806 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.66341929 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.53580630 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.50805305 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.42653547 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.31937451 |
| 9 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.31470808 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.24558934 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.00509989 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.00108261 |
| 13 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.96401160 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.95017559 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89443444 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86988414 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.85052653 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.82862761 |
| 19 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.82313119 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.76697739 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.75410659 |
| 22 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.73797916 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72669966 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.71038717 |
| 25 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.70391705 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.69458017 |
| 27 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.63566413 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.59289882 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57882656 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.57534369 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.56149285 |
| 32 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.55356228 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.50825093 |
| 34 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.50674577 |
| 35 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.50411948 |
| 36 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.47912258 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 1.44339422 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.42905525 |
| 39 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.38307361 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38262541 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.37484419 |
| 42 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.35645834 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33443285 |
| 44 | NCOR_22424771_ChIP-Seq_293T_Human | 1.32745774 |
| 45 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31308774 |
| 46 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31308774 |
| 47 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30758613 |
| 48 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.29097192 |
| 49 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.27723447 |
| 50 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.27377231 |
| 51 | AR_20517297_ChIP-Seq_VCAP_Human | 1.27082995 |
| 52 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26633743 |
| 53 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.25434846 |
| 54 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.25434846 |
| 55 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.25209115 |
| 56 | GATA3_26560356_Chip-Seq_TH2_Human | 1.23202155 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21774092 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.21683264 |
| 59 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.21231338 |
| 60 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.20886533 |
| 61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.20866084 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19499738 |
| 63 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17663550 |
| 64 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.17641758 |
| 65 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.17021617 |
| 66 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.16913240 |
| 67 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15597392 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14293142 |
| 69 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.13946627 |
| 70 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.13673430 |
| 71 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12969467 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.09871964 |
| 73 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.09259408 |
| 74 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.08216502 |
| 75 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.08216502 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08010965 |
| 77 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.05459044 |
| 78 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05131520 |
| 79 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03617714 |
| 80 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02623735 |
| 81 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01221803 |
| 82 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99617764 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99047424 |
| 84 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98615905 |
| 85 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.98009017 |
| 86 | ERA_21632823_ChIP-Seq_H3396_Human | 0.97312116 |
| 87 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.97015180 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.96670819 |
| 89 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.96140929 |
| 90 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.93830680 |
| 91 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.92317426 |
| 92 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.92152218 |
| 93 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91371821 |
| 94 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91058608 |
| 95 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.90822823 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89667560 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87588991 |
| 98 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87329991 |
| 99 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.87301198 |
| 100 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87221164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.19296162 |
| 2 | MP0002138_abnormal_hepatobiliary_system | 2.89943846 |
| 3 | MP0003646_muscle_fatigue | 2.83625214 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.70443754 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 2.35417804 |
| 6 | MP0002837_dystrophic_cardiac_calcinosis | 2.32678492 |
| 7 | MP0001986_abnormal_taste_sensitivity | 2.14396706 |
| 8 | MP0004043_abnormal_pH_regulation | 2.13283254 |
| 9 | MP0004147_increased_porphyrin_level | 2.07301223 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.03059871 |
| 11 | MP0008877_abnormal_DNA_methylation | 1.99473467 |
| 12 | MP0003806_abnormal_nucleotide_metabolis | 1.98400381 |
| 13 | MP0000685_abnormal_immune_system | 1.94276528 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 1.93093901 |
| 15 | MP0002006_tumorigenesis | 1.89670408 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 1.87295037 |
| 17 | MP0002638_abnormal_pupillary_reflex | 1.87026242 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 1.86257053 |
| 19 | MP0009785_altered_susceptibility_to | 1.80702837 |
| 20 | MP0006072_abnormal_retinal_apoptosis | 1.79749105 |
| 21 | MP0001919_abnormal_reproductive_system | 1.77590054 |
| 22 | MP0001984_abnormal_olfaction | 1.75851170 |
| 23 | MP0005084_abnormal_gallbladder_morpholo | 1.70969529 |
| 24 | MP0003718_maternal_effect | 1.67801625 |
| 25 | MP0006082_CNS_inflammation | 1.65000662 |
| 26 | MP0004145_abnormal_muscle_electrophysio | 1.63936475 |
| 27 | MP0006292_abnormal_olfactory_placode | 1.63468708 |
| 28 | MP0008872_abnormal_physiological_respon | 1.56847120 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.56522185 |
| 30 | MP0005551_abnormal_eye_electrophysiolog | 1.55654889 |
| 31 | MP0005646_abnormal_pituitary_gland | 1.50461383 |
| 32 | MP0005389_reproductive_system_phenotype | 1.50437050 |
| 33 | MP0001800_abnormal_humoral_immune | 1.49331626 |
| 34 | MP0009745_abnormal_behavioral_response | 1.45340720 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.44658748 |
| 36 | MP0001905_abnormal_dopamine_level | 1.42266313 |
| 37 | MP0002163_abnormal_gland_morphology | 1.37582575 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.37520476 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.37311019 |
| 40 | MP0001873_stomach_inflammation | 1.36584997 |
| 41 | MP0002736_abnormal_nociception_after | 1.35933445 |
| 42 | MP0005083_abnormal_biliary_tract | 1.34778257 |
| 43 | MP0001970_abnormal_pain_threshold | 1.33568398 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.33148701 |
| 45 | MP0002723_abnormal_immune_serum | 1.28831583 |
| 46 | MP0001790_abnormal_immune_system | 1.28040118 |
| 47 | MP0005387_immune_system_phenotype | 1.28040118 |
| 48 | MP0000613_abnormal_salivary_gland | 1.24379516 |
| 49 | MP0003880_abnormal_central_pattern | 1.22101194 |
| 50 | MP0009764_decreased_sensitivity_to | 1.21667505 |
| 51 | MP0002876_abnormal_thyroid_physiology | 1.19611204 |
| 52 | MP0001819_abnormal_immune_cell | 1.18688050 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.17978262 |
| 54 | MP0005310_abnormal_salivary_gland | 1.17195050 |
| 55 | MP0002272_abnormal_nervous_system | 1.16793707 |
| 56 | MP0002166_altered_tumor_susceptibility | 1.16763833 |
| 57 | MP0002733_abnormal_thermal_nociception | 1.15967487 |
| 58 | MP0003786_premature_aging | 1.15641771 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.15432821 |
| 60 | MP0003787_abnormal_imprinting | 1.13349956 |
| 61 | MP0004142_abnormal_muscle_tone | 1.13248677 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.13137152 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.11678405 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.10053987 |
| 65 | MP0009046_muscle_twitch | 1.03431525 |
| 66 | MP0000569_abnormal_digit_pigmentation | 1.03169935 |
| 67 | MP0002405_respiratory_system_inflammati | 1.02759588 |
| 68 | MP0005332_abnormal_amino_acid | 0.97796820 |
| 69 | MP0005025_abnormal_response_to | 0.97542832 |
| 70 | MP0003638_abnormal_response/metabolism_ | 0.97497412 |
| 71 | MP0003866_abnormal_defecation | 0.96844040 |
| 72 | MP0001845_abnormal_inflammatory_respons | 0.96807867 |
| 73 | MP0005379_endocrine/exocrine_gland_phen | 0.95608737 |
| 74 | MP0002234_abnormal_pharynx_morphology | 0.95578045 |
| 75 | MP0005394_taste/olfaction_phenotype | 0.95346809 |
| 76 | MP0005499_abnormal_olfactory_system | 0.95346809 |
| 77 | MP0003186_abnormal_redox_activity | 0.95144475 |
| 78 | MP0005670_abnormal_white_adipose | 0.93489266 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 0.93327665 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.92211180 |
| 81 | MP0005075_abnormal_melanosome_morpholog | 0.90386387 |
| 82 | MP0001853_heart_inflammation | 0.88574166 |
| 83 | MP0000372_irregular_coat_pigmentation | 0.88388218 |
| 84 | MP0008469_abnormal_protein_level | 0.86541726 |
| 85 | MP0001502_abnormal_circadian_rhythm | 0.85339784 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.84784366 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.83061253 |
| 88 | MP0005253_abnormal_eye_physiology | 0.82672936 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.82601902 |
| 90 | MP0002064_seizures | 0.82513749 |
| 91 | MP0003195_calcinosis | 0.80214450 |
| 92 | MP0002693_abnormal_pancreas_physiology | 0.80155832 |
| 93 | MP0008995_early_reproductive_senescence | 0.78793969 |
| 94 | MP0000716_abnormal_immune_system | 0.78051488 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.76728399 |
| 96 | MP0003724_increased_susceptibility_to | 0.75852289 |
| 97 | MP0003011_delayed_dark_adaptation | 0.75605339 |
| 98 | MP0005174_abnormal_tail_pigmentation | 0.73779365 |
| 99 | MP0002210_abnormal_sex_determination | 0.73694419 |
| 100 | MP0002095_abnormal_skin_pigmentation | 0.73180589 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 3.89809923 |
| 2 | Pancreatic cysts (HP:0001737) | 3.57892682 |
| 3 | Hypoproteinemia (HP:0003075) | 3.56384969 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.52716277 |
| 5 | Abnormality of midbrain morphology (HP:0002418) | 3.49016099 |
| 6 | Molar tooth sign on MRI (HP:0002419) | 3.49016099 |
| 7 | Pancreatic fibrosis (HP:0100732) | 3.48019209 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.40900966 |
| 9 | Progressive macrocephaly (HP:0004481) | 3.38993808 |
| 10 | Congenital stationary night blindness (HP:0007642) | 3.35387104 |
| 11 | Acute encephalopathy (HP:0006846) | 3.30437661 |
| 12 | 3-Methylglutaconic aciduria (HP:0003535) | 3.27970979 |
| 13 | IgG deficiency (HP:0004315) | 3.24181536 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.22429072 |
| 15 | Increased CSF lactate (HP:0002490) | 3.16992024 |
| 16 | True hermaphroditism (HP:0010459) | 3.03335983 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 2.99989022 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.99989022 |
| 19 | Stomatitis (HP:0010280) | 2.95645063 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.93457601 |
| 21 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.93457601 |
| 22 | Hemoptysis (HP:0002105) | 2.90219374 |
| 23 | Congenital, generalized hypertrichosis (HP:0004540) | 2.84709291 |
| 24 | Chronic diarrhea (HP:0002028) | 2.79314407 |
| 25 | Abnormality of the prostate (HP:0008775) | 2.77759243 |
| 26 | Hepatic necrosis (HP:0002605) | 2.74829341 |
| 27 | Microretrognathia (HP:0000308) | 2.62447407 |
| 28 | Generalized aminoaciduria (HP:0002909) | 2.60536224 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 2.57958564 |
| 30 | Thyroiditis (HP:0100646) | 2.57802791 |
| 31 | Severe combined immunodeficiency (HP:0004430) | 2.55123945 |
| 32 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52931596 |
| 33 | Abolished electroretinogram (ERG) (HP:0000550) | 2.45147544 |
| 34 | Constricted visual fields (HP:0001133) | 2.45019246 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 2.43594057 |
| 36 | Anencephaly (HP:0002323) | 2.43078380 |
| 37 | Renal Fanconi syndrome (HP:0001994) | 2.42495302 |
| 38 | Cystic liver disease (HP:0006706) | 2.41749150 |
| 39 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.37567543 |
| 40 | Abnormality of T cell number (HP:0011839) | 2.31155640 |
| 41 | Optic disc pallor (HP:0000543) | 2.29994896 |
| 42 | Aplastic anemia (HP:0001915) | 2.27186088 |
| 43 | Nephronophthisis (HP:0000090) | 2.25941726 |
| 44 | Lissencephaly (HP:0001339) | 2.21696731 |
| 45 | Cerebral edema (HP:0002181) | 2.21457232 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 2.19426440 |
| 47 | Increased serum lactate (HP:0002151) | 2.19192087 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 2.18385619 |
| 49 | Obstructive lung disease (HP:0006536) | 2.18385619 |
| 50 | Agitation (HP:0000713) | 2.16614925 |
| 51 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.16442407 |
| 52 | Lactic acidosis (HP:0003128) | 2.14309059 |
| 53 | Alveolar cell carcinoma (HP:0006519) | 2.13444638 |
| 54 | Hypoalbuminemia (HP:0003073) | 2.12860058 |
| 55 | Abnormal albumin level (HP:0012116) | 2.12860058 |
| 56 | T lymphocytopenia (HP:0005403) | 2.10166123 |
| 57 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.09371645 |
| 58 | Pendular nystagmus (HP:0012043) | 2.06960900 |
| 59 | Renal cortical cysts (HP:0000803) | 2.06295246 |
| 60 | Tubulointerstitial nephritis (HP:0001970) | 2.03483991 |
| 61 | Exertional dyspnea (HP:0002875) | 2.02120795 |
| 62 | Pancytopenia (HP:0001876) | 2.00882838 |
| 63 | Fair hair (HP:0002286) | 2.00680808 |
| 64 | Increased IgM level (HP:0003496) | 1.99582922 |
| 65 | Abnormality of T cells (HP:0002843) | 1.95048612 |
| 66 | Opisthotonus (HP:0002179) | 1.94551970 |
| 67 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93595100 |
| 68 | Glycosuria (HP:0003076) | 1.92629196 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 1.92629196 |
| 70 | Absent/shortened dynein arms (HP:0200106) | 1.92062157 |
| 71 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.92062157 |
| 72 | Type II lissencephaly (HP:0007260) | 1.91888893 |
| 73 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91350342 |
| 74 | Bifid tongue (HP:0010297) | 1.90111976 |
| 75 | Pachygyria (HP:0001302) | 1.89260035 |
| 76 | Cerebral palsy (HP:0100021) | 1.89164225 |
| 77 | Male pseudohermaphroditism (HP:0000037) | 1.87843699 |
| 78 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.87290456 |
| 79 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.85685247 |
| 80 | Cerebral hypomyelination (HP:0006808) | 1.84983315 |
| 81 | Attenuation of retinal blood vessels (HP:0007843) | 1.84466507 |
| 82 | Bile duct proliferation (HP:0001408) | 1.83902305 |
| 83 | Abnormal biliary tract physiology (HP:0012439) | 1.83902305 |
| 84 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.83405517 |
| 85 | Hypoplasia of the brainstem (HP:0002365) | 1.83405517 |
| 86 | Abnormal drinking behavior (HP:0030082) | 1.82735458 |
| 87 | Polydipsia (HP:0001959) | 1.82735458 |
| 88 | Combined immunodeficiency (HP:0005387) | 1.80567828 |
| 89 | Postaxial foot polydactyly (HP:0001830) | 1.79641585 |
| 90 | Abnormality of the labia minora (HP:0012880) | 1.76994515 |
| 91 | Abnormality of the pleura (HP:0002103) | 1.76641665 |
| 92 | Increased muscle lipid content (HP:0009058) | 1.76183565 |
| 93 | Lethargy (HP:0001254) | 1.75835010 |
| 94 | Sclerocornea (HP:0000647) | 1.75398699 |
| 95 | Cleft eyelid (HP:0000625) | 1.74689931 |
| 96 | Dyschromatopsia (HP:0007641) | 1.73259703 |
| 97 | Meningitis (HP:0001287) | 1.72779022 |
| 98 | Gangrene (HP:0100758) | 1.71224554 |
| 99 | Hypothermia (HP:0002045) | 1.70343811 |
| 100 | Ureteral stenosis (HP:0000071) | 1.70284648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.86271724 |
| 2 | FRK | 3.49876815 |
| 3 | GRK1 | 3.36857785 |
| 4 | MAP3K12 | 3.07158971 |
| 5 | NUAK1 | 2.74487435 |
| 6 | TLK1 | 2.60889968 |
| 7 | ADRBK2 | 2.47639857 |
| 8 | CDK19 | 2.37184138 |
| 9 | KDR | 2.13632496 |
| 10 | BMPR2 | 2.13246210 |
| 11 | NTRK2 | 2.04576169 |
| 12 | ZAK | 2.03553496 |
| 13 | FES | 1.94572565 |
| 14 | WNK3 | 1.88191910 |
| 15 | PINK1 | 1.85946616 |
| 16 | TAOK3 | 1.84854295 |
| 17 | WNK4 | 1.79266647 |
| 18 | OXSR1 | 1.78899589 |
| 19 | MAP4K2 | 1.77003118 |
| 20 | BUB1 | 1.72973640 |
| 21 | NTRK1 | 1.56679592 |
| 22 | MST4 | 1.40974451 |
| 23 | ITK | 1.39683802 |
| 24 | BCKDK | 1.36825652 |
| 25 | MYLK | 1.36139181 |
| 26 | MAPKAPK3 | 1.23801802 |
| 27 | STK16 | 1.21571581 |
| 28 | PRKCQ | 1.18254625 |
| 29 | BRSK1 | 1.14853578 |
| 30 | TIE1 | 1.11203065 |
| 31 | MAP3K13 | 1.09932369 |
| 32 | IKBKB | 1.09652619 |
| 33 | LIMK1 | 1.03003220 |
| 34 | PIK3CA | 1.02066124 |
| 35 | AURKA | 0.99540941 |
| 36 | STK39 | 0.98693216 |
| 37 | INSRR | 0.98611000 |
| 38 | CSNK1G2 | 0.96043748 |
| 39 | MUSK | 0.92539969 |
| 40 | NEK1 | 0.91360895 |
| 41 | DYRK2 | 0.88707796 |
| 42 | TSSK6 | 0.84632042 |
| 43 | MINK1 | 0.81065276 |
| 44 | GRK6 | 0.80964415 |
| 45 | PRKCG | 0.80589607 |
| 46 | PDK2 | 0.77900464 |
| 47 | TEC | 0.77632138 |
| 48 | UHMK1 | 0.76623800 |
| 49 | EPHB2 | 0.72433891 |
| 50 | BMPR1B | 0.72230253 |
| 51 | PRKCH | 0.69967371 |
| 52 | JAK3 | 0.68066263 |
| 53 | PLK1 | 0.67949448 |
| 54 | LCK | 0.67870638 |
| 55 | SYK | 0.67827277 |
| 56 | TESK2 | 0.67789049 |
| 57 | KIT | 0.67345938 |
| 58 | VRK1 | 0.66215467 |
| 59 | MARK3 | 0.63686394 |
| 60 | PLK3 | 0.62872069 |
| 61 | SIK3 | 0.62672296 |
| 62 | OBSCN | 0.61251758 |
| 63 | ADRBK1 | 0.60354595 |
| 64 | DAPK1 | 0.60344852 |
| 65 | NME2 | 0.58171205 |
| 66 | LYN | 0.54228693 |
| 67 | PRKACA | 0.52473363 |
| 68 | VRK2 | 0.51959712 |
| 69 | GRK7 | 0.50906501 |
| 70 | IKBKE | 0.49474967 |
| 71 | BTK | 0.49445958 |
| 72 | MAPKAPK5 | 0.49322718 |
| 73 | CSNK1G3 | 0.49233458 |
| 74 | CAMK2A | 0.49027864 |
| 75 | PRKCA | 0.48876671 |
| 76 | PLK2 | 0.47546296 |
| 77 | CSK | 0.47277485 |
| 78 | PRKD3 | 0.45963077 |
| 79 | ROCK1 | 0.45180008 |
| 80 | CSF1R | 0.41460641 |
| 81 | PRKCZ | 0.40171585 |
| 82 | CSNK2A2 | 0.39038379 |
| 83 | MAPK11 | 0.38960963 |
| 84 | TAF1 | 0.38294610 |
| 85 | NME1 | 0.37615139 |
| 86 | IGF1R | 0.36661592 |
| 87 | CSNK2A1 | 0.36155094 |
| 88 | PRKCI | 0.35934899 |
| 89 | PRKG1 | 0.35452095 |
| 90 | MAP2K6 | 0.35403541 |
| 91 | STK11 | 0.33993490 |
| 92 | ERBB3 | 0.32808550 |
| 93 | SIK2 | 0.32471130 |
| 94 | MAPK13 | 0.32424816 |
| 95 | AURKB | 0.32022734 |
| 96 | TYRO3 | 0.30934627 |
| 97 | PRKCE | 0.30361178 |
| 98 | ERBB2 | 0.29531067 |
| 99 | CSNK1G1 | 0.29527178 |
| 100 | RPS6KA5 | 0.28296466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 4.36131718 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.01168529 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.68925172 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.61935374 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.40766416 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.25655635 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.15314993 |
| 8 | Proteasome_Homo sapiens_hsa03050 | 3.12150304 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.73939453 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.23566121 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 2.22383791 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.17298066 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.16589296 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.05516391 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.03892077 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.89708897 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.81963890 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.74656814 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.74502802 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68069846 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62317782 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51651258 |
| 23 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.47543037 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41246580 |
| 25 | Phototransduction_Homo sapiens_hsa04744 | 1.38171360 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.35788087 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 1.31927412 |
| 28 | Sulfur relay system_Homo sapiens_hsa04122 | 1.25142843 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.19432350 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.05448565 |
| 31 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00598650 |
| 32 | Basal transcription factors_Homo sapiens_hsa03022 | 1.00256964 |
| 33 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.00169877 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.99326642 |
| 35 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97416209 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96210765 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94300794 |
| 38 | Nicotine addiction_Homo sapiens_hsa05033 | 0.93415235 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92834442 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.92384738 |
| 41 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91835142 |
| 42 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.85363252 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.83393601 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.77718623 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 0.77611579 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74939051 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70360732 |
| 48 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.70107332 |
| 49 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67753065 |
| 50 | Leishmaniasis_Homo sapiens_hsa05140 | 0.67290260 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.66771751 |
| 52 | Morphine addiction_Homo sapiens_hsa05032 | 0.65640024 |
| 53 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.62785964 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 0.57725543 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56197188 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.56154760 |
| 57 | Purine metabolism_Homo sapiens_hsa00230 | 0.54528193 |
| 58 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.53612960 |
| 59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52851952 |
| 60 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.52190697 |
| 61 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51457861 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50900101 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.49942662 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49748882 |
| 65 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48272370 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47837126 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44263377 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43955128 |
| 69 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43901703 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.43729119 |
| 71 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40403925 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38994658 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38616577 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.38080761 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36515635 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35565987 |
| 77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34267514 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.34233703 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.33813524 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33362915 |
| 81 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32651765 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.31656304 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.31447104 |
| 84 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.30862425 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.30032084 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29346932 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.29001362 |
| 88 | Base excision repair_Homo sapiens_hsa03410 | 0.28771433 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.26638870 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25896352 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.25600202 |
| 92 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24368239 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.23854844 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.23253914 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.22665541 |
| 96 | Taste transduction_Homo sapiens_hsa04742 | 0.22644326 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.21883768 |
| 98 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.21102906 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.20874564 |
| 100 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.20796760 |

